John Harrison
John Harrison, MA, PsyD(c),
was principal investigator of MAPS’ pilot study investigating the efficacy of Ibogaine in the treatment of opiate addiction, and has presented this research at over 25 conferences worldwide. He’s a psychologist in private practice, specializing in addiction treatment and personal transformation.
The Psychedelic Renaissance: Reconsidering Psychedelics in 2018
Jul 27 - 29, 2018 Begins in 3 months
with John Harrison & Ben Sessa
In this workshop, we’ll explore the remarkable potential of psychedelics for healing and self-discovery around the world. We will examine current topics of research including the use of MDMA in the treatment of post-traumatic stress disorder (PTSD) and social anxiety disorder among autistic adults. Ketamine will also be in focus as a remedy for treatment-resistant depression and anxiety in the face of terminal illness.